Table 2a.
Table 2A Abundance of Nup358, Bicd2 and Rab6 in human organisms, normalized to Nup358 | |||||
---|---|---|---|---|---|
Human dataset (quality score) | Nup358 | Rab6 | BicD2 | ||
Human peptide atlas 2014 (26.0) | 1 | 2.5 | 0.4 | ||
Global proteome machine 2014 (23.9) | 1 | 11.0 | 0.4 | ||
Integrated Human Proteome (15.5) | 1 | 6.4 | 0.4 | ||
Average ratio | 1 | 6.6 ± 4.3 | 0.4 ± 0 | ||
BicD1 | BicDRI | BicDR2 | α&β Tubulin | ||
Human peptide atlas 2014 (26.0) | 0.05 | 0 | 0.08 | 307 | |
Global proteome machine 2014 (26.0) | 0.11 | 0 | 0.05 | ||
Integrated human proteome (26.0) | 0.03 | 0 | 0.06 | 698 | |
Average ratio | 0.06 ± 0.04 | 0 | 0.06 ± 0.02 | 503 ± 200 | |
Table 2B Cytosolic concentration of human Nup358, BicD2 and Rab6 | |||||
Nup358 G1 phase | Rab6 | BicD2 | BicD1 & BicDR2 | α&β Tubulin (Control) | |
Molecules per cell | 32000 | 211000 | 13000 | 4000 | 1.5*107 |
Cytosolic conc. (nM) | 40 | 268 | 16 | 5 | 20000 |
Data was obtained from the protein abundance database.55 The protein abundance data quality score is based on the assumption that interacting proteins from a complex have a tendency to have similar abundance, and a large score indicates high data quality. All available data sets from whole human organisms were used, which reported abundance for all three proteins.55,67,68 As a control, the cellular concentration of αβ-tubulin combined was calculated using the same method, which fits well with the cellular concentration of tubulin reported in the literature (e.g., 25 μM and 12−18 μM58–60).